News
Guides, lab handling, storage and research insights from our team.
alcohol cravings
Aug 12, 2026
Retatrutide and Alcohol Cravings: Can the Triple-Agonist Outperform Tirzepatide?Retatrutide, a triple-agonist peptide, is being explored for alcohol cravings, but it lacks FDA approval. Could it outperform tirzepatide? Evidence...Read article
alcohol use disorder
Aug 05, 2026
Retatrutide in VA Alcohol Use Disorder Trials: Could the Triple-Agonist Outperform Tirzepatide for Veterans?The VA is testing retatrutide, a triple-agonist peptide, for alcohol use disorder. Could it outperform tirzepatide? This article examines the...Read article